Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2000
06/22/2000CA2355066A1 Extending graft survival by heme oxygenase-i expression induced immunomodulation
06/22/2000CA2354765A1 The process for manufacturing formulation of topical beta blockers with improved efficacy
06/22/2000CA2354601A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males
06/22/2000CA2354591A1 4-aryloxindoles as inhibitors of jnk protein kinases
06/22/2000CA2354543A1 Compositions and methods for the treatment of anorectal disorders
06/22/2000CA2354527A1 Integrative protein-dna cochleate formulations and methods for transforming cells
06/22/2000CA2354401A1 Method and system with electronic control devices for blending of chinese herbal medicine
06/22/2000CA2353593A1 Method of administering a compound to multi-drug resistant cells
06/22/2000CA2352613A1 New pharmaceutical formulation
06/22/2000CA2352056A1 Microemulsions containing water and hydrofluoroethers
06/21/2000EP1010707A1 Process for preparing aqueous polymer dispersions
06/21/2000EP1010435A1 Nanocapsule preparations for treating intraarticular diseases
06/21/2000EP1010423A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
06/21/2000EP1010416A1 Nanoemulsion based on fatty esters of glycerol and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology
06/21/2000EP1010415A1 Nanoemulsion based on fatty esters of oxyethylated or non- oxylated sorbitan and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology
06/21/2000EP1010414A1 Nanoemulsion based on mixed esters of a fatty acid or alcohol, of a carboxylic acid and glyceryl, and uses thereof in the cosmetical, dermatological and/or ophtalmological fields
06/21/2000EP1010413A1 Nanoemulsion based on fatty acid esters of sugar or fatty ethers of sugar and uses thereof in the cosmetical, dermatological and/or ophtalmological fields
06/21/2000EP1009759A1 Carbohydrate crosslinked glycoprotein crystals
06/21/2000EP1009524A1 Improvements in or relating to capsules
06/21/2000EP1009438A1 Dried biologically or therapeutically active preparations
06/21/2000EP1009434A1 Stabilizers containing recombinant human serum albumin for live virus vaccines
06/21/2000EP1009430A1 Vaccines
06/21/2000EP1009429A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
06/21/2000EP1009428A1 Vaginal suppository vaccine for urogenital infections
06/21/2000EP1009414A2 Novel pharmaceutical composition
06/21/2000EP1009410A1 Method for producing stable acetylsalicylic acid solutions
06/21/2000EP1009409A1 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate
06/21/2000EP1009408A1 New combination of antiasthma medicaments
06/21/2000EP1009406A1 Pharmaceutical composition for the administration of thiocolchicoside via the buccal mucosa
06/21/2000EP1009394A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol
06/21/2000EP1009393A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
06/21/2000EP1009392A2 Drain system containing additives
06/21/2000EP1009391A1 Improved method for preventing crystal formation in a scopolamine transdermal device
06/21/2000EP1009390A1 Prolonged anesthesia in joints and body spaces
06/21/2000EP1009389A1 Improvements in or relating to capsules
06/21/2000EP1009388A1 Sustained release drug delivery devices
06/21/2000EP1009387A1 Stabilized sustained release tramadol formulations
06/21/2000EP1009386A1 Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
06/21/2000EP1009385A2 Cholesterol lowering composition
06/21/2000EP1009384A1 A method of administering liposomal encapsulated taxane
06/21/2000EP1009383A1 Oral liposomal delivery system
06/21/2000EP1009382A1 Oil in water emulsions containing saponins
06/21/2000EP1009381A1 Carotenoid microemulsions
06/21/2000EP1009380A1 Method for preparing pharmaceutical formulations
06/21/2000EP1009369A1 Oral compositions
06/21/2000EP0825875B1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
06/21/2000EP0820304B1 Chlamydia vaccines
06/21/2000DE19958427A1 Drug for curing migraine and the preparation method
06/21/2000DE19858372A1 Vitaminpräparat, Verfahren zu seiner Herstellung und seine Verwendung Vitamin preparation, process for its preparation and its use
06/21/2000DE19857897A1 Verfahren zur Herstellung wäßriger Polymerdispersionen A process for preparing aqueous polymer dispersions
06/21/2000DE19857816A1 Fließfähige, pressfertige Arzneimittelvorprodukte für Tabletten, Pellets und Dragees, sowie Verfahren zu deren Herstellung Flowable, press-ready drug precursors for tablets, pellets, and dragees, and to processes for their preparation
06/21/2000DE19857716A1 Neue feste Formulierung von Metrifonat New solid formulation of metrifonate
06/21/2000CN1257480A Compound, preparation and use for transferring nucleic acids into cells
06/21/2000CN1257474A New nitromethyl ketones, process for preparing them and compositions containing them
06/21/2000CN1257431A Chemically and thermally stable norastemizole formulations
06/21/2000CN1257430A Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
06/21/2000CN1257425A Gastroretentive controlled release microspheres for improved drug delivery
06/21/2000CN1257424A Composition comprising finely divided, crystalling particles of budesonide
06/21/2000CN1257423A Preparation of powder agglomerates
06/21/2000CN1257422A Solid pharmaceutical preparation
06/21/2000CN1257421A Medicinal aerosol products
06/21/2000CN1257420A Keratotic plug remover
06/21/2000CN1257079A Process for preparing polymer water dispersate
06/21/2000CN1256948A Oral medicine for treating cranial nerve system disease and preparation process thereof
06/21/2000CN1256943A Ointment for promoting muscle growth
06/21/2000CN1256940A Lidanhoubao lozenge
06/21/2000CN1256931A Traditional Chinese medicine for treating uremia and fortifying kidney and productive method thereof
06/21/2000CN1256928A Skin-cleaning medicine (Jiefuning)
06/21/2000CN1256925A Medicine for stopping drug-taking
06/21/2000CN1256915A Acid sensitive empty precursor liposome and preparation and its application in package biological technology products
06/21/2000CN1053667C Inhibiting photodecomposition of 3-substituted-2-oxindoles
06/21/2000CN1053658C Aminostilbazole derivative and medicine
06/21/2000CN1053591C Nitroglycerine adhesive plaster and process for preparing same
06/21/2000CN1053590C Frozen dried heptitis A toxicity-reduced biovaccine and protective agent thereof
06/21/2000CN1053584C Capsule for treating stubborn pain or numbness and preparation process thereof
06/21/2000CN1053581C Yunnan Baiyao (white drug-powder) tablet and preparation method thereof
06/21/2000CN1053579C Capsule for treating gastric diseases
06/21/2000CN1053570C Pharmaceutical composition of piperidinoalkanol-decongestant combination preparation process
06/21/2000CN1053569C Injectable solution and process for preparing same
06/20/2000USRE36744 Nasal administration of benzodiazepine hypnotics
06/20/2000US6077916 Biodegradable mixtures of polyphoshazene and other polymers
06/20/2000US6077867 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
06/20/2000US6077843 Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
06/20/2000US6077839 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists
06/20/2000US6077834 Combining non-viral receptor ligand and cationic lipid ; adding polynucleotide to form molecular mixture; introducing molecular mixture to cell to enhance delivery of polynucleotide to cell
06/20/2000US6077829 Comprising brain derived neurotrophic factor(bdnf), polyoxyethylene sorbitan monooleate as nonionic surfactant, and carrier; prevents denaturing and polymerization of bdnf; storage stability
06/20/2000US6077544 Protective coating to mask taste; tablet drug delivery; time-release agents
06/20/2000US6077543 Atomizing solutions to produce drops; lung drug delivery
06/20/2000US6077542 Heating valproic acid, dissolving sodium valproate therein, cooling below melting point
06/20/2000US6077541 Enteric coating; capsules
06/20/2000US6077540 Sodium, magnesium or potassium sulfate drying agent; tablets
06/20/2000US6077539 Rapid bioavailability of metoclopramide; long acting non-steroidal antiinflammatory agent; free of ht3 receptor antagonists; side effect reduction
06/20/2000US6077538 Sodium carboxymethylcellulose, sodium bicarbonate, hydroxypropylmethyl cellulose, hydroxypropyl cellulose and magnesium stearate; analgesic and opiod drug delivery
06/20/2000US6077537 Non-sedating acrivastine product
06/20/2000US6077536 Pharmaceutical formulation
06/20/2000US6077535 Sorbitol carrier
06/20/2000US6077534 Production of pharmaceutical formulations for treatment of edema and venous disorders
06/20/2000US6077533 Powder-layered oral dosage forms
06/20/2000US6077532 Pharmaceutical ion exchange resin composition
06/20/2000US6077531 Capsule with micronized progesterone suspension in oil and estradiol in microspheres; menopause
1 ... 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 2482 2483 2484 2485 2486 2487 2488 2489 2490 2491 2492 ... 2991